CCN1 EXPRESSION BY FIBROBLASTS HAS A ROLE IN BLEOMYCIN INDUCED SKIN FIBROSIS AND IS A POTENTIAL TARGET FOR ANTI-FIBROTIC THERAPY IN SCLERODERMA

被引：0
|
作者：
Quensel, K. [1 ]
Hutchenreuther, J. [1 ]
Xu, S. [2 ]
Hinz, B. [3 ]
Siqueira, W. [1 ]
O'Gorman, D. [4 ]
Stratton, R. [2 ]
Leask, A. [1 ]
机构：
[1] Univ Western Ontario, Dent, London, England
[2] UCL, London, England
[3] Univ Toronto, Toronto, ON, Canada
[4] Lawson Res Inst, London, ON, Canada
来源：
WOUND REPAIR AND REGENERATION | 2020年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
A-109
引用
收藏
页码：A12 / A12
页数：1
相关论文
共 39 条
  • [21] EXPRESSION OF MARKERS FOR PERICYTES AND MYOFIBROBLASTS IN BLEOMYCIN-INDUCED DERMAL FIBROSIS: POTENTIAL ROLE OF NEUROPEPTIDE RECEPTORS IN A MOUSE MODEL FOR SCLERODERMA
    Ibrahim, Mohamed M.
    McKinnon, Elizabeth
    Sunday, Mary E.
    Levinson, Howard
    WOUND REPAIR AND REGENERATION, 2017, 25 (04) : A41 - A41
  • [22] The Depsipeptide Hdac Inhibitor Fk228 Has Potent Anti-Fibrotic Properties In Ipf Fibroblasts And Decreases The Expression Of Lysyl Oxidase A Potential Ipf Biomarker
    Davies, E. R.
    Calderwood, C.
    Jones, M. G.
    Hoile, L.
    Thatcher, T. H.
    Sime, P. J.
    Maher, T. M.
    O'Reilly, K. M. A.
    Davies, D. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [23] Discovery of a chalcone derivative as an anti-fibrotic agent targeting transforming growth factor-β1 signaling: Potential therapy of renal fibrosis
    Poolsri, Wanangkan
    Noitem, Rattikarn
    Jutabha, Promsuk
    Raveesunthornkiat, Manasanan
    Danova, Ade
    Chavasiri, Warinthorn
    Muanprasat, Chatchai
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [24] Expression of Markers for Pericytes and Myofibroblasts in Bleomycin (Bleo)-Induced Dermal Fibrosis: Potential Role of Neuropeptide Receptors in a Mouse Model for Scleroderma (SSc)
    McKinnon, Elizabeth
    Parra, James
    Ibrahim, Mohammad
    Levinson, Howard
    Sunday, Mary E.
    MODERN PATHOLOGY, 2017, 30 : 134A - 134A
  • [25] Expression of Markers for Pericytes and Myofibroblasts in Bleomycin (Bleo)-Induced Dermal Fibrosis: Potential Role of Neuropeptide Receptors in a Mouse Model for Scleroderma (SSc)
    McKinnon, Elizabeth
    Parra, James
    Ibrahim, Mohammad
    Levinson, Howard
    Sunday, Mary E.
    LABORATORY INVESTIGATION, 2017, 97 : 134A - 134A
  • [26] PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model
    Leduc, Martin
    Grouix, Brigitte
    Gervais, Liette
    Sarra-Bournet, Francois
    Tremblay, Mikael
    Laurin, Pierre
    Gagnon, Lyne
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [27] Pbi-4425, A Novel First-In-Class Anti-Inflammatory/anti-Fibrotic Compound, Inhibits Collagen I And CTgf Production In Human Fibroblasts, And Reduces Lung Fibrosis In The Bleomycin-Induced Lung Fibrosis Model
    Leduc, M.
    Tremblay, M.
    Grouix, B.
    Sarra-Bournet, F.
    Felton, A.
    Laurin, P.
    Gagnon, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [28] Pbi-4050, A Novel First-In-Class Anti-Fibrotic Compound, Inhibits CTgf And Collagen I Production In Human Alveolar Epithelial Cells And Fibroblasts, And Reduces Lung Fibrosis In The Bleomycin-Induced Lung Fibrosis Model
    Leduc, M.
    Tremblay, M.
    Grouix, B.
    Sarra-Bournet, F.
    Felton, A.
    Laurin, P.
    Gagnon, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [29] TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma
    Maeki-Opas, Ilari
    Haemaelaeinen, Mari
    Moilanen, Eeva
    Scotece, Morena
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [30] TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma
    Ilari Mäki-Opas
    Mari Hämäläinen
    Eeva Moilanen
    Morena Scotece
    Arthritis Research & Therapy, 25
1234